ESR2 and breast cancer: Taken together, the increased expression of ESR2, combined with the reduced expression of key mitochondrial and antioxidant regulators, suggests that obesity-related inflammation enhances the aggressive phenotype of luminal breast cancer through a compromised mitochondrial and antioxidant response.